On-demand webinar
Introducing Advyser Blood Suite - RHD: Smarter analysis for Devyser RHD
Non-invasive fetal RHD screening supports targeted anti-D prophylaxis, helping avoid unnecessary treatment while identifying pregnancies where anti-D prophylaxis may be indicated. In this webinar, we will briefly introduce the role of RHD screening with Devyser RHD, our real-time PCR assay, followed by a practical demonstration of Advyser Blood Suite – RHD, the software that supports analysis and interpretation of Devyser RHD results.
In this webinar, we will explore:
- Understand the Rh blood group system, its clinical significance in pregnancy, and how fetal RHD screening supports targeted anti-D prophylaxis as per with the current recommendations
- Get an overview of Devyser RHD and its real-time PCR workflow
- Get a demo of Advyser Blood Suite -RHD and learn how it supports data analysis of results from Devyser RHD
Latest from the Devyser blog
View all
Devyser launches a new updated NGS assay to simplify thalassemia testing
Devyser has launched Devyser Thalassemia v2, a next-generation sequencing (NGS) solution designed...
Read More
Devyser Thalassemia achieves 99.9% sensitivity: Insights from a recent study
Thalassemia and hemoglobinopathies are among the most common genetic disorders worldwide, affecting...
Read More
New insights into thalassemia: Latest studies using Devyser Thalassemia for NGS testing
Read More